Access cutting-edge breast cancer treatment through this clinical trial at a research site in Jackson. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Jackson at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
Study LAE205INT3101 is a Phase Ib/III study to evaluate the efficacy and safety of the combination therapy with afuresertib plus fulvestrant (afuresertib/placebo plus fulvestrant in Phase III) in patients with HR+/HER2- breast cancer who have failed 1 to 2 prior lines of endocrine therapy, and/or CDK4/6 inhibitor (up to 1 therapy), and/or chemotherapy (up to 1 chemotherapy) as described in the inclusion criteria.
Sponsor: Laekna Limited
Check if you qualify for this breast cancer clinical trial in Jackson, MS
If you're searching for breast cancer treatment options in Jackson, MS, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Jackson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.